The synthetic molecule stauprimide impairs cell growth and migration in triple-negative breast cancer
Stauprimide, a semi-synthetic derivative of staurosporine, is known mainly for its potent differentiation-enhancing properties in embryonic stem cells. Here, we studied the effects of stauprimide in cell growth and migration of triple-negative breast cancer cells in vitro, evaluating its potential a...
Main Authors: | P. Carrillo, M. Bernal, C. Téllez-Quijorna, A.D. Marrero, I. Vidal, L. Castilla, C. Caro, A. Domínguez, M.L. García-Martín, A.R. Quesada, M.A. Medina, B. Martínez-Poveda |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-02-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222014597 |
Similar Items
-
Hydrogen sulfide and its donors: Novel antitumor and antimetastatic therapies for triple-negative breast cancer
by: Haonan Li, et al.
Published: (2020-07-01) -
A Novel Paclitaxel Derivative for Triple-Negative Breast Cancer Chemotherapy
by: Yuetong Liu, et al.
Published: (2023-04-01) -
Immunity and cancer: role of tumor-infiltrating lymphocytes in triple-negative breast cancer
by: Ana Tečić-Vuger, et al.
Published: (2021-01-01) -
Stauprimide Priming of Human Embryonic Stem Cells toward Definitive Endoderm
by: Yaser Tahamtani, et al.
Published: (2014-03-01) -
The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast Cancer: A Multicenter Cross-Sectional Study in Indonesia
by: Jeffry Beta Tenggara, et al.
Published: (2023-10-01)